Boult Wade Tennant
/es

Archivos: Boletines

octubre 3, 2023

The EPO’S guidelines and machine learning

The EPO has published its Guidelines to provide guidance on various proceedings before the EPO, such as for the search and examination

Training data in patent specifications – the direction of travel

With the recent expansion in artificial intelligence (AI) and machine learning technologies, and an associated rise in the number of AI related

EPO Board of Appeal highlights difficulties in establishing inventive step in machine learning cases

A recent decision from the EPO’s Technical Boards of Appeal (T2803/18) highlights a pitfall for applicants wishing to patent systems and methods

Assessing patentability in artificial intelligence patent applications at the EPO

As artificial intelligence (AI) continues to advance and transform various industries, the protection of AI-related inventions through patents becomes increasingly important. Artificial

septiembre 21, 2023

China’s consultation proposes significant amendments to its trademark law

China is proposing to overhaul its trade mark law, largely in an effort to combat the scourge of bad faith filings. On

septiembre 19, 2023

The end of the EPO’s ten-day notification rule

The EPO’s plans to abolish the 10-day notification rule will come into force on 1 November 2023. With just a month to

septiembre 17, 2023

UKIPO guidance update: Address for Service

The UK Intellectual Property Office (IPO) has recently updated its guidance relating to Address for Service (AFS) in the UK. The guidance

agosto 27, 2023

Proposed changes to US patent law – patent eligibility, inter partes review and post grant review

In June 2023, the US Senate proposed changes to US patent law to address patent subject matter eligibility, inter partes reviews and

agosto 17, 2023

T 56/21 – The latest in the EPO’s ongoing saga of description amendments.

In a previous bulletin we reported on the EPO’s ever more onerous requirements for amending the description to conform with any amendments

agosto 11, 2023

Neurim Overturned – CJEU severely restricts availability of second medical use SPCs

The Court of Justice of the European Union (CJEU) has ruled in Santen (C‑673/18) that a Supplementary Protection Certificate (SPC) cannot be